RecruitingNot ApplicableNCT06700460

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

A Randomized Evaluation of Clinical Outcomes Following Bilateral Implantation of EVO+ ICL Lenses or Bilateral Wavefront-Optimized LASIK (EVOlve)

Sponsor

Vance Thompson Vision

Enrollment

56 participants

Start Date

Nov 27, 2024

Study Type

INTERVENTIONAL

Conditions

Myopia

Summary

Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

Eligibility

Min Age: 21 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Implantable Collamer Lens placement and a medical device called Laser-assisted in Situ Keratomileusis for people with myopia. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 21 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.